Anish P. Mahajan

Suggest Changes

Writes About:

Learn More
BACKGROUND In most resource-constrained countries, CD4 cell count testing is prohibitively expensive for routine clinical use and is not widely available. As a result, physicians are often required(More)
BACKGROUND A major obstacle to the administration of highly active antiretroviral therapy (HAART) in resource-limited settings is the high cost of CD4 count testing. The total lymphocyte count (TLC)(More)